Table 2 Details of each patient who received Meek grafts
From: Retrospective review of a tertiary adult burn centre’s experience with modified Meek grafting
Patient No. | Age (years) | Gender | TBSA burn (%) | Region | TBSA receiving Meek grafts (%) | Take rate (%) | Microbiology |
|---|---|---|---|---|---|---|---|
1 | 39 | Male | 78 | Back | 8 | 100 | none |
2 | 64 | Female | 20 | Lower limbs | 12 | 33 | Pseudomonas, Candida |
3 | 47 | Male | 41 | Back | 18 | 72 | Acinetobacter |
4 | 52 | Male | 60 | Flank/chest/ Lower limb | 4 | 25 | Pseudomonas, Candida |
5 | 58 | Female | 55 | Back/ abdomen/ upper limb | 18 | 100 | none |
6 | 36 | Male | 85 | Back/ abdomen/ upper limb | 32 | 100 | none |
7 | 23 | Male | 75 | Back/ chest/ abdomen | 35 | 86 | Enterobacter |
8 | 49 | Female | 40 | Flanks/ shoulder | 5 | 100 | MRSA |
9 | 77 | Male | 38 | Back | 14 | 100 | none |
10 | 46 | Male | 60 | Back | 12 | 83 | Pseudomonas |
11 | 18 | Female | 63 | Back | 18 | 100 | MRSA |